Soonmee Cha, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Soonmee Cha, MD

Assistant Professor, Department of Radiology, UCSF

Phone: (415) 353-1537 (appts)
Box 0628, UCSF
San Francisco, CA 94143-0628

View on UCSF Profiles

Cancer Center Membership

Associate Member » Neurologic Oncology

Research Summary

Soonmee Cha, MD, is a Professor In Residence of Radiology and Neurological Surgery at the University of California, San Francisco.  Dr. Cha has focused on the importance of validating the usefulness of MRI as a tool for brain tumor diagnosis and monitoring and identifying therapy endpoints. She obtained her medical degree from Georgetown University, School of Medicine, Washington in 1991, and completed her residency in Diagnostic Radiology from North Shore University Hospital, Cornell University Medical College in New York, followed by a fellowship in Neuroradiology from New York University Medical Center in 1998.

Dr. Cha is committed to a career dedicated to patient-oriented research in the field of brain tumor imaging. She believes that non-invasive imaging technology will make important contributions to the health of patients through improving the specificity and precision of diagnosis and treatment monitoring, which will have significant impact on therapeutic decisions.

The main focus of Dr. Cha’s research is to identify reliable surrogate markers of prognosis and therapeutic efficacy by quantitative MR imaging methods in patients with brain tumors. She believes that by using MR imaging techniques such perfusion MR imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging, detection of changes in tumor angiogenesis, cellularity, invasion, tumor hypoxia, and metabolic burden can be accurately measured and will provide more specific information about patient’s early response to therapy in the context of tumor growth.

Dr. Cha has been awarded for several NIH grants where she served as Principal Investigator and Co-Principal Investigator. She has published 87 articles, and she has written 77 peer-reviewed articles and 4 book chapters.

Expertise:

Neuroradiology

Specialty:

Brain tumor imaging

Professional Interests:

Brain tumor, brain cancer, glioblastoma multiforme, gliomas, primary cerebral lymphoma, angiogenesis, hypoxia, invasion, perfusion MR imaging, diffusion-weighted imaging, molecular imaging, biomarkers, microarray, genomics, neural stem cell

Education and Training:

• Medical School: Georgetown University, College of Arts and Sciences, Washington, District of Columbia

• Internship: Georgetown University Fairfax Hospital, Falls Church

• Residency: North Shore University Hospital, Cornell University Medical College, Manhasset, New York - Diagnostic Radiology

• Fellowship: New York University Medical Center, New York - Neuroradiology

• National Board of Medical Examiners

• American Board of Radiology

• New York State Medical License

• Certificate of Added Qualification Neuroradiology

• California State Medical License

Education

Georgetown University, Washington, DC, B.S., 1983-1987, Chemistry
Georgetown University, Washington, DC, M.D., 1987-1991, Medicine
Georgetown University Hospital, Washington, DC, Internship, 1991-1992, Transitional Internship
North Shore University Hospital, Manhasset, NY, Residency, 1992-1996, Diagnostic Radiology
New York University Medical Center, New York, NY, Fellowship, 1996-1998, Neuroradiology


Professional Experience

  • 1997-1998
    Clinical Instructor of Neuroradiology, New York University Medical Center, New York, NY
  • 1998-2000
    Assistant Professor of Radiology, New York University School of Medicine
  • 2001-present
    Assistant Professor of Radiology, University of California, San Francisco School of Medicine

Honors & Awards

  • April 2000
    ASNR Outstanding Presentation Award in General Neuroradiology at the 38th Annual Meeting in Atlanta, GA.
  • 1995
    Certificate of Merit Award, Scientific exhibit at RSNA
  • 1994
    Certificate of Merit Award, Scientific exhibit at RSNA

Selected Publications

  1. CNS angiitis as a brain tumor mimic with a branching vascular abnormality on T2* MRI. Neurology. 2015 Nov 17; 85(20):1819-20.
    View on PubMed
  2. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms. AJR Am J Roentgenol. 2015 Nov; 205(5):1075-85.
    View on PubMed
  3. Adult-onset central nervous system hemophagocytic lymphohistiocytosis: a case report. BMC Neurol. 2015; 15(1):203.
    View on PubMed
  4. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol. 2015 Sep; 17(9):1188-98.
    View on PubMed
  5. From Shades of Gray to Microbiologic Imaging: A Historical Review of Brain Abscess Imaging: RSNA Centennial Article. Radiographics. 2015 Sep-Oct; 35(5):1555-62.
    View on PubMed
  6. The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma†. Neuro Oncol. 2016 Jan; 18(1):87-95.
    View on PubMed
  7. Surgical Management of Intracranial Neuroenteric Cysts: The UCSF Experience. J Neurol Surg B Skull Base. 2015 Dec; 76(6):475-9.
    View on PubMed
  8. Modern brain tumor imaging. Brain Tumor Res Treat. 2015 Apr; 3(1):8-23.
    View on PubMed
  9. Reduced apparent diffusion coefficient in neuromyelitis optica-associated optic neuropathy. J Neuroophthalmol. 2015 Mar; 35(1):101-2.
    View on PubMed
  10. Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma. Case Rep Radiol. 2015; 2015:731361.
    View on PubMed
  11. Frontal operculum gliomas: language outcome following resection. J Neurosurg. 2015 Apr; 122(4):725-34.
    View on PubMed
  12. Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy. CNS Oncol. 2014 Nov; 3(6):407-19.
    View on PubMed
  13. Apparent diffusion coefficient in glioblastoma with PNET-like components, a GBM variant. J Neurooncol. 2014 Sep; 119(2):353-60.
    View on PubMed
  14. Intrameningioma metastasis of breast carcinoma. Rare Tumors. 2014 May 13; 6(2):5313.
    View on PubMed
  15. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014 Jan 10; 343(6167):189-93.
    View on PubMed
  16. Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03). Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):659-64.
    View on PubMed
  17. Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma. Clin Cancer Res. 2014 Feb 15; 20(4):1029-41.
    View on PubMed
  18. Plating after tibial lengthening: unilateral monoaxial external fixator and locking plate. J Pediatr Orthop B. 2013 Nov; 22(6):571-6.
    View on PubMed
  19. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood. 2013 Jun 6; 121(23):4740-8.
    View on PubMed
  20. Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme. Neuro Oncol. 2013 Apr; 15(4):480-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI